Understanding New Options for CLL: Session 2 Replay

Published on

Topics include: Treatments

In the replay of session two of our “Understanding New Options for CLL” town meeting, a panel of experts discusses strategies for managing life with CLL. Learn more about coping with disease symptoms, treatment side effects and emotional aspects of CLL. In the final chapter of the program, an audience of CLL patients and their loved ones poses their questions to the panel in a Q&A session.

Provided by CLL Global Research Foundation, which received support from AbbVie Inc., Genentech Inc., Gilead Sciences, Pharmacyclics, Inc., Teva Pharmaceuticals and TG Therapeutics. In partnership with The University of Texas MD Anderson Cancer Center.

View more programs featuring , , , and

Produced in association with and

Related Programs

Dr. Michael Keating: My Perspective on CLL Research News

What CLL research advances are in the pipeline, and will they be available to everyone soon? Dr. Michael Keating explains.


Exploring Second-Generation CLL Inhibitors

Why should patients be interested in second-generation CLL inhibitors? Drs. Lamanna and Thompson explain.


Checkpoint Inhibitors and CLL

Could checkpoint inhibitors be used to treat CLL? CLL expert, Dr. Nicole Lamanna, explains.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on May 24, 2019